Progressive visual field defects from experimental glaucoma: Measurements with white and colored stimuli

Optometry and Vision Science

Volumn 76, Issue 8, 1999, Pages 558-570

  Harwerth, Ronald S ^a,c   Smith III, Earl L ^b   Chandler, Michael ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b ALCON RESEARCH LTD   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

Animal model; Automated perimetry; Color mechanisms; Glaucoma; Psychophysics

Indexed keywords

COLOR; CORRELATION METHODS; REGRESSION ANALYSIS; VISION;

GLAUCOMA; PERIMETRY; PSYCHOPHYSICS; VISUAL FIELD DEFECTS;

OPHTHALMOLOGY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLOR; CONTROLLED STUDY; GLAUCOMA; MONKEY; NONHUMAN; PERIMETRY; PRIORITY JOURNAL; RETINA GANGLION CELL; VISUAL FIELD DEFECT; VISUAL THRESHOLD;

ANIMALS; COLOR; DISEASE PROGRESSION; GLAUCOMA; MACACA FASCICULARIS; MACACA MULATTA; PERIMETRY; PHOTIC STIMULATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SENSORY THRESHOLDS; VISUAL FIELDS;

EID: 0032773751     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006324-199908000-00025     Document Type: Article

References (72)

1. Anderson DR. Perimetry with and without Automation, 2nd ed. St. Louis: Mosby, 1987.
2. Alexander LJ. Diagnosis and management of primary open-angle glaucoma. In: Classe JG, ed. Optometry Clinics, vol 1. Nonvalk: Appleton & Lange, 1991:19-102.
3. Quigley HA. Open-angle glaucoma. N Engl J Med 1993:328: 1097-106.
4. Epstein DL. Primary open angle glaucoma. In: Chandler PA, Grant WM, Epstein DL, Allingham RR, Schuman JS, eds. Chandler and Grant's Glaucoma, 4th ed. Baltimore: Williams & Wilkins, 1997: 183-98.
5. Anderson DR. Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture. Am J Ophthalmol 1989; 108: 485-95.
6. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischémie neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982:100:135-46.
7. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989; 107:453-64.
8. Hanverth RS, Carter-Dawson L, Shen F, Smith EL 3rd, Crawford ML. Ganglion cell losses underlying visual field defects from glaucoma. Invest Ophthalmol Vis Sci 1999, in press.
9. Tyler CW. Specific deficits of flicker sensitivity in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1981;20:204-12.
10. Adams AJ, Rodic R, Husted R, Stamper R. Spectral sensitivity and color discrimination changes in glaucoma and glaucoma-suspect patients. Invest Ophthalmol Vis Sci 1982;23:516-24.
11. Silverman SE, Trick GL, Hart WM Jr. Motion perception is abnormal in primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1990;31:722-9.
12. Sample PA, Weinreb RN. Color perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1990:31:1869-75.
13. Johnson CA, Adams AJ, Casson EJ, Brandt JD. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 1993;111:645-50.
14. Bullimore MA, Wood JM, Swenson K. Motion perception in glaucoma. Invest Ophthalmol Vis Sci 1993:34:3526-33.
15. Harwerth RS, Smith EL 3rd, DeSantis L. Perimetric indices for the progression of visual field defects using colored test stimuli. Invest Ophthalmol Vis Sci 1994;35(Suppl):2184.
16. Wild JM, Moss ID, Whitaker D, O'Neill EC. The statistical interpretation of blue-on-yellow visual field loss. Invest Ophthalmol Vis Sci 1995:36:1398-410.
17. Johnson CA. The Glenn A. Fry Award Lecture. Early losses of visual function in glaucoma. Optom Vis Sci 1995:72:359-70.
18. Greenstein VC, Halevy D, Zaidi Q, Koenig KL, Ritch RH. Chromatic and luminance systems deficits in glaucoma. Vision Res 1996; 36:621-9.
19. Johnson CA. Diagnostic value of short-wavelength automated perimetry. Curr Opinion Ophthalmol 1996:7:54-8.
20. Wall M, Ketoff KM. Random dot motion perimetry in patients with glaucoma and in normal subjects. Am J Ophthalmol 1995;120: 587-96.
21. Hanverth RS, Smith EL 3rd. Contrast sensitivity perimetry: investigations with degenerate gratings. In: Wall M, Heijl A, eds. Perimetry Update 1996/1997. Amsterdam: Kugler Publications, 1997:3-12.
22. Lynch S, Johnson CA, Demirel S. Is early damage in glaucoma selective for a particular cell type or pathway? In: Wall M, Heijl A, eds. Perimetry Update 1996/1997. Amsterdam: Kugler Publications, 1997:253-61.
23. Bosworth CF, Sample PA, Weinreb RN. Motion perception thresholds in areas of glaucomatous visual field loss. Vision Res 1997:37: 355-64.
24. Wall M, Jennisch CS, Munden PM. Motion perimetry identifies nerve fiber bundlelike defects in ocular hypertension [see comments]. Arch OphthaJmol 1997:115:26-33.
25. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci 1997:38:413-25.
26. Sample PA, Bosworth CF, Weinreb RN. Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma. Arch Ophthalmol 1997:115:1129-33.
27. Teesalu P, Vihanninjoki K, Airaksinen PJ, Tuulonen A, Laara E. Correlation of blue-on-yellow visual fields with scanning confocal laser optic disc measurements. Invest Ophthalmol Vis Sci 1997:38: 2452-9.
28. Johnson C. Selective vs. nonselective losses in glaucoma. J Glaucoma 1994;3:S32-S44.
29. Alvarez SL, Pierce GE, Vingrys AJ, Benes SC, Weber PA, King-Smith PE. Comparison of red-green, blue-yellow and achromatic losses in glaucoma. Vision Res 1997:37:2295-301.
30. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988;95:357-63.
31. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 1991:32:484-91.
32. Smith EL 3rd, Chino YM, Harwerth RS, Ridder WH, Crawford MLJ. Retinal inputs to the monkey's lateral geniculate nucleus in experimental glaucoma. Clin Vis Sci 1993:8:113-39.
33. Vickers JC, Schumer RA, Podos SM, Wang RF, Riederer BM, Morrison JH. Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res 1995:680:23-35.
34. Desatnik H, Quigley HA, Glovinsky Y. Study of central retinal ganglion cell loss in experimental glaucoma in monkey eyes. J Glaucoma 1996:5:46-53.
35. Porciatti V, Di Bartolo E, Nardi N, Fiorentini A. Responses to chromatic and luminance contrast in glaucoma: a psychophysical and electrophysiological study. Vision Res 1997:37:1975-87.
36. Felius J, Swanson WH, Fellman RL, Lynn JR, Starita RJ. Spatial summation for selected ganglion cell mosaics in patients with glaucoma. In: Wall M, Heijl A, eds. Perimetry Update 1996/1997. Amsterdam: Kugler Publications, 1997:213-21.
37. Flammer J, Drance SM, Augustiny L, Funkhouser A. Quantification of glaucomatous visual field defects with automated perimetry. Invest Ophthalmol Vis Sci 1985:26:176-81.
38. Heijl A, Lindgren G, Olsson J. A package for the statistical analysis of visual fields. Doc Ophthalmol 1987:49:153-68.
39. Heijl A, Lindgren G, Olsson J. Reliability parameters in computerized perimetry. Doc Ophthalmol 1987:49:595-600.
40. Wood JM, Bruce AS. The value of visual field indexes in screening and threshold testing of glaucoma. Glaucoma 1993:15:140-6.
41. Katz J, Sommer A, Gaasterland DE, Anderson DR. Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol 1991:109:1684-9.
42. Asman P, Heijl A. Glaucoma Hemifield Test. Automated visual field evaluation. Arch Ophthalmol 1992:110:812-19.
43. Asman P, Heijl A. Evaluation of methods for automated Hemifield analysis in perimetry. Arch Ophthalmol 1992;110:820-6.
44. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol 1986;101:l-6.
45. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci 1996:37:1419-28.
46. Harwerth RS, Smith EL 3rd, DeSantis L. Experimental glaucoma: perimetric field defects and intraocular pressure. J Glaucoma 1997; 6:390-401.
47. Harwerth RS, Smith EL 3rd, DeSantis L. Behavioral perimetry in monkeys. Invest Ophthalmol Vis Sci 1993:34:31-40.
48. Schumer RA, Podos SM. The nerve of glaucomal Arch Ophthalmol 1994:112:37-44.
49. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36:774-86.
50. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996;114:299-305.
51. Nickells RW. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma 1996;5:345-56.
52. De Valois RL, Abramov I, Jacobs GH. Analysis of response patterns of LGN cells. J Opt SocAm 1966;56:966-77.
53. Sperling HG, Harwerth RS. Red-green cone interactions in the increment-threshold spectral sensitivity of primates. Science 1971 ; 172: 180-4.
54. King-Smith PE, Kranda K. Photopic adaptation in the red-green spectral range. Vision Res 1981;21:565-72.
55. Hart WM Jr, Silverman SE, Trick GL, Nesher R, Gordon MO. Glaucomatous visual field damage. Luminance and color-contrast sensitivities. Invest Ophthalmol Vis Sci 1990:31:359-67.
56. Heron G, Adams AJ, Husted R. Central visual fields for short wavelength sensitive pathways in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci 1988;29:64-72.
57. Kalloniatis M, Harwerth RS. Spectral sensitivity and adaptation characteristics of cone mechanisms under white-light adaptation. J Opt SocAm (A) 1990:7:1912-28.
58. Shapley R. Visual sensitivity and parallel retinocortical channels. Annu Rev Psychol 1990:41:635-58.
59. Harwerth RS, Smith EL 3rd, DeSantis L. Mechanisms mediating visual detection in static perimetry. Invest Ophthalmol Vis Sci 1993; 34:3011-23.
60. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol 1974; 13:455-7.
61. Pederson JE, Gaasterland DE. Laser-induced primate glaucoma. I. Progression of cupping. Arch Ophthalmol 1984;102:1689-92.
62. Quigley HA, Hohman RM. Laser energy levels for trabecular meshwork damage in the primate eye. Invest Ophthalmol Vis Sci 1983; 24:1305-7.
63. Kalloniatis M, Harwerth RS, Smith EL 3rd, DeSantis L. Colour vision anomalies following experimental glaucoma in monkeys. Ophthalmic Physiol Opt 1993:13:56-67.
64. Harwerth RS, Smith EL 3rd. Visual field defects in glaucoma: Gabor patch vs. Goldmann III test targets. Invest Ophthalmol Vis Sci 1996; 37:S509.
65. Anderson RS, O'Brien C. Psychophysical evidence for a selective loss of M ganglion cells in glaucoma. Vision Res 1997:37:1079-83.
66. de Monasterio FM. Asymmetry of on- and off-pathways of bluesensitive cones of the retina of macaques. Brain Res 1979:166:39-48.
67. Dacey DM. Physiology, morphology and spatial densities of identified ganglion cell types in primate retina. In: Bock GR, Goode JA, eds. Higher-Order Processing in the Visual System. New York: Wiley & Sons, 1994:12-28.
68. Dacey DM, Lee BB. The 'blue-on' opponent pathway in primate retina originates from a distinct bistratified ganglion cell type. Nature 1994:367:731-5.
69. Newsome WT, Britten KH, Movshon JA. Neuronal correlates of a perceptual decision. Nature 1989:341:52-4.
70. Britten KH, Shadlen MN, Newsome WT, Movshon JA. The analysis of visual motion: a comparison of neuronal and psychophysical performance. J Neurosci 1992;12:4745-65.
71. Norren DV, Vos JJ. Spectral transmission of the human ocular media. Vision Res 1974;l4:1237-44.
72. Savage GL, Haegerstrom-Portnoy G, Adams AJ, Hewlett SE. Age changes in the optical density of human ocular media. Clin Vision Sci 1993:8:97-108.